Intraoperative Radiation Therapy

Global Intraoperative Radiation Therapy Market to Reach US$94.7 Million by 2030

The global market for Intraoperative Radiation Therapy estimated at US$63.7 Million in the year 2023, is expected to reach US$94.7 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Systems / Accelerators, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$22.9 Million by the end of the analysis period. Growth in the Applicators & Afterloaders segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$16.8 Million While China is Forecast to Grow at 8.9% CAGR

The Intraoperative Radiation Therapy market in the U.S. is estimated at US$16.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$21.7 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Intraoperative Radiation Therapy Market - Key Trends and Drivers Summarized

How Is Intraoperative Radiation Therapy Revolutionizing Cancer Treatment?

Intraoperative radiation therapy (IORT) is an innovative cancer treatment that delivers a concentrated dose of radiation to a tumor site during surgery. This technique allows for more precise targeting of cancer cells while minimizing exposure to surrounding healthy tissues. IORT is particularly effective in treating breast cancer, gastrointestinal cancers, and certain types of sarcomas, where it can be difficult to remove all cancerous tissue through surgery alone. By delivering radiation directly to the tumor bed, IORT reduces the risk of cancer recurrence and shortens the overall treatment time for patients, offering a more efficient and effective approach to cancer care.

What Technological Innovations Are Driving Intraoperative Radiation Therapy?

Advancements in radiation delivery systems and imaging technologies are enhancing the effectiveness of intraoperative radiation therapy. Modern linear accelerators used in IORT are capable of delivering high doses of radiation in a single session, reducing the number of treatments required compared to conventional radiotherapy. Real-time imaging technologies, such as intraoperative CT and MRI, are improving the precision of radiation delivery by providing surgeons with a clear view of the tumor site during the procedure. These innovations are enabling more accurate treatment and improving patient outcomes by minimizing radiation exposure to healthy tissues and ensuring that the full dose is delivered to the tumor.

How Do Market Segments Define the Growth of Intraoperative Radiation Therapy?

Technologies include electron-based IORT, X-ray-based IORT, and high-dose-rate (HDR) brachytherapy, with electron-based IORT being the most widely used due to its ability to target deep-seated tumors. Applications of IORT include breast cancer, colorectal cancer, and sarcomas, with breast cancer representing one of the largest segments due to the widespread adoption of IORT in breast-conserving surgeries. End-users include hospitals, cancer treatment centers, and ambulatory surgical centers, with hospitals leading the market due to their advanced surgical and radiotherapy infrastructure. The market is expanding rapidly in regions such as North America and Europe, where cancer treatment protocols are evolving to incorporate new technologies like IORT.

What Factors Are Driving the Growth in the Intraoperative Radiation Therapy Market?

The growth in the intraoperative radiation therapy (IORT) market is driven by several factors, including the increasing incidence of cancer, the growing preference for breast-conserving surgeries, and advancements in radiation delivery technologies. IORT’s ability to deliver targeted, high-dose radiation during surgery is making it an attractive option for oncologists and surgeons looking to minimize treatment times and reduce the risk of recurrence. Additionally, the rising demand for personalized cancer treatments, combined with the ongoing development of more precise radiation equipment, is propelling market growth. Expanding healthcare infrastructure in emerging markets is also contributing to the adoption of IORT, as hospitals and cancer centers invest in advanced oncology treatments.

Select Competitors (Total 36 Featured) -

• Ariane Medical Systems, Ltd.
• Eckert & Ziegler Group
• Elekta AB
• GMV Innovating Solutions
• iCAD, Inc.
• IntraOp Medical Corporation
• Sensus Healthcare, Inc.
• Sordina IORT Technologies S.p.A.
• Varian Medical Systems, Inc.
• ZEISS Group

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.